On 2025-05-12, Aquestive Therapeutics, Inc. (AQST) announced earnings per share of $-0.24 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.17.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.18 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.17 | $-0.24 |
| 2025-03-05 | 2024-12-31 | $-0.14 | $-0.19 |
| 2024-11-04 | 2024-09-30 | $-0.12 | $-0.13 |
| 2024-08-06 | 2024-06-30 | $-0.11 | $-0.03 |
| 2024-05-07 | 2024-03-31 | $-0.09 | $-0.17 |
| 2024-03-05 | 2023-12-31 | $-0.08 | $-0.12 |
| 2023-11-06 | 2023-09-30 | $-0.11 | $-0.03 |
| 2023-08-07 | 2023-06-30 | $-0.11 | $-0.10 |
| 2023-05-02 | 2023-03-31 | $-0.10 | $0.11 |
| 2023-03-07 | 2022-12-31 | $-0.21 | $-0.23 |
| 2022-11-01 | 2022-09-30 | $-0.30 | $-0.23 |
| 2022-08-02 | 2022-06-30 | $-0.41 | $-0.36 |
| 2022-05-03 | 2022-03-31 | $-0.45 | $-0.32 |
| 2022-03-08 | 2021-12-31 | $-0.37 | $-0.38 |
| 2021-11-02 | 2021-09-30 | $-0.40 | $-0.37 |
| 2021-08-03 | 2021-06-30 | $-0.42 | $-0.33 |
| 2021-05-04 | 2021-03-31 | $-0.44 | $-0.41 |
| 2021-03-09 | 2020-12-31 | $-0.46 | $-0.60 |
| 2020-11-04 | 2020-09-30 | $-0.50 | $-0.49 |
| 2020-08-04 | 2020-06-30 | $-0.43 | $-0.07 |
| 2020-05-05 | 2020-03-31 | $-0.52 | $-0.49 |
| 2020-03-11 | 2019-12-31 | $-0.45 | $-0.48 |
| 2019-11-05 | 2019-09-30 | $-0.78 | $-0.54 |
| 2019-08-06 | 2019-06-30 | $-0.67 | $-0.82 |
| 2019-05-08 | 2019-03-31 | $-0.49 | $-0.59 |
| 2019-03-14 | 2018-12-31 | $-0.91 | $-0.56 |
| 2018-11-06 | 2018-09-30 | $-0.49 | $-0.49 |
| 2018-09-04 | 2018-06-30 | -- | $-1.90 |